Noncoding deletions reveal a gene that is critical for intestinal function

Danit Oz-Levi, Tsviya Olender, Ifat Bar-Joseph, Yiwen Zhu, Dina Marek-Yagel, Iros Barozzi, Marco Osterwalder, Anna Alkelai, Elizabeth K. Ruzzo, Yujun Han, Erica S.M. Vos, Haike Reznik-Wolf, Corina Hartman, Raanan Shamir, Batia Weiss, Rivka Shapiro, Ben Pode-Shakked, Pavlo Tatarskyy, Roni Milgrom, Michael SchvimerIris Barshack, Denise M. Imai, Devin Coleman-Derr, Diane E. Dickel, Alex S. Nord, Veena Afzal, Kelly Lammerts van Bueren, Ralston M. Barnes, Brian L. Black, Christopher N. Mayhew, Matthew F. Kuhar, Amy Pitstick, Mehmet Tekman, Horia C. Stanescu, James M. Wells, Robert Kleta, Wouter de Laat, David B. Goldstein, Elon Pras, Axel Visel, Doron Lancet*, Yair Anikster, Len A. Pennacchio

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Large-scale genome sequencing is poised to provide a substantial increase in the rate of discovery of disease-associated mutations, but the functional interpretation of such mutations remains challenging. Here we show that deletions of a sequence on human chromosome 16 that we term the intestine-critical region (ICR) cause intractable congenital diarrhoea in infants1,2. Reporter assays in transgenic mice show that the ICR contains a regulatory sequence that activates transcription during the development of the gastrointestinal system. Targeted deletion of the ICR in mice caused symptoms that recapitulated the human condition. Transcriptome analysis revealed that an unannotated open reading frame (Percc1) flanks the regulatory sequence, and the expression of this gene was lost in the developing gut of mice that lacked the ICR. Percc1-knockout mice displayed phenotypes similar to those observed upon ICR deletion in mice and patients, whereas an ICR-driven Percc1 transgene was sufficient to rescue the phenotypes found in mice that lacked the ICR. Together, our results identify a gene that is critical for intestinal function and underscore the need for targeted in vivo studies to interpret the growing number of clinical genetic findings that do not affect known protein-coding genes.

Original languageEnglish
Pages (from-to)107-111
Number of pages5
JournalNature
Volume571
Issue number7763
DOIs
StatePublished - 4 Jul 2019

Funding

FundersFunder number
Cincinnati Children’s Hospital and Sheba Medical Center
David and Elaine Potter Charitable FoundationHL064658, HL089707, HL136182
National Institutes of Health1R01DK092456, 1U18NS080815, P30 DK0789392
National Heart, Lung, and Blood InstituteR24HL123879
National Human Genome Research InstituteUM1HG009421, R01HG003988, U54HG006997
National Institute of General Medical SciencesR35GM119831
Seventh Framework Programme241544
Weizmann Institute of Science
Wolfson Family Charitable Trust
Crown Human Genome Center

    Fingerprint

    Dive into the research topics of 'Noncoding deletions reveal a gene that is critical for intestinal function'. Together they form a unique fingerprint.

    Cite this